These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 33437907)

  • 1. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
    Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.
    Bhagavathula AS; Woolf B; Rahmani J; Vidyasagar K; Tesfaye W
    Eur J Clin Pharmacol; 2022 Apr; 78(4):547-555. PubMed ID: 35039907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
    Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
    JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
    Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
    Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
    Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
    J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.
    Kennedy OJ; Roderick P; Buchanan R; Fallowfield JA; Hayes PC; Parkes J
    BMJ Open; 2017 May; 7(5):e013739. PubMed ID: 28490552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin in Patients with Viral Hepatitis: Systematic Review and Meta-Analysis of Observational Studies.
    Bian W; Bian W; Li Q; Li Y
    J Gastrointest Cancer; 2024 Jun; 55(2):638-651. PubMed ID: 38557825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
    Tan RZH; Lockart I; Abdel Shaheed C; Danta M
    Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
    Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
    Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
    Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
    J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
    Arvind A; Memel ZN; Philpotts LL; Zheng H; Corey KE; Simon TG
    Metabolism; 2021 Jul; 120():154780. PubMed ID: 33891949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials.
    Kraglund F; Christensen DH; Eiset AH; Villadsen GE; West J; Jepsen P
    Hepatol Commun; 2023 Jan; 7(1):e0013. PubMed ID: 36633465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
    Lee TY; Hsu YC; Tseng HC; Lin JT; Wu MS; Wu CY
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2784-2792.e7. PubMed ID: 32360983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.
    Petrick JL; Sahasrabuddhe VV; Chan AT; Alavanja MC; Beane-Freeman LE; Buring JE; Chen J; Chong DQ; Freedman ND; Fuchs CS; Gaziano JM; Giovannucci E; Graubard BI; Hollenbeck AR; Hou L; Jacobs EJ; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Purdue MP; Rosenberg L; Schairer C; Sesso HD; Sigurdson AJ; Wactawski-Wende J; Zeleniuch-Jacquotte A; Campbell PT; McGlynn KA
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1156-62. PubMed ID: 26391917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
    Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
    Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
    J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.